For example, tumor-infiltrating T cells express high levels of the coinhibitory molecules PD-1 and CTLA-4, thereby enabling immune checkpoint blockade therapies to prevent the ligand-binding–induced inhibitory signals. This evidence concerns the gene PDCD1 and neoplasm.